FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Novartis Wins Expanded Approval for Scemblix

FDA grants an accelerated approval to Novartis for its supplemental NDA for Scemblix (asciminib) for the drugs expanded use in treating newly diagnose...

latest-news-card-1
FDA General

Trump as President May Tap RFK for FDA Head

Former president Donald Trump appears to be leaning toward elevating former presidential candidate and now supporter Robert F. Kennedy, Jrs health rol...

latest-news-card-1
Human Drugs

FDA Wont Require Qsymia CV Outcome Trial

FDA says it no longer requires a cardiovascular outcome trial for Vivus Qsymia weight-loss pill.

latest-news-card-1
Human Drugs

PharmaTher Complete Response Letter on Ketamine

FDA sends PharmaTher a complete response letter on its ANDA for Ketarx (ketamine) and its use in anesthesia, sedation, and pain, among other uses.

latest-news-card-1
Medical Devices

De Novo Authorization for Dexter Surgical Robot

FDA grants Distalmotion a de novo marketing authorization for the Dexter Surgical Robot for adult inguinal hernia repair.

latest-news-card-1
Medical Devices

Paragonix Kidney Preservation Transport Device Cleared

FDA clears a Paragonix Technologies 510(k) for its transportable perfusion device KidneyVault and its use in kidney preservation.

latest-news-card-1
Human Drugs

House GOPs Demand Clinical Data on Puberty Blockers

House Republicans demand the release of clinical data from taxpayer-funded research involving a study of puberty-blocking drugs that were not publishe...

latest-news-card-1
Federal Register

Info Collection on Antimicrobial Animal Drug Sales

Federal Register notice: FDA seeks comments on an information collection extension entitled Antimicrobial Animal Drug Sales and Distribution21 CFR 514...

latest-news-card-1
Human Drugs

Broader FDA Interpretations Needed for Review Vouchers: Hill

A bipartisan Congressional effort seeks broader FDA interpretations when awarding priority review vouchers.